VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
46 hedge funds and large institutions have $7.06M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 24 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
96% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 50
Holders
46
Holding in Top 10
–
Calls
$536K
Puts
$6K
Top Buyers
| 1 | +$292K | |
| 2 | +$224K | |
| 3 | +$131K | |
| 4 |
Jane Street
New York
|
+$37.7K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$19.6K |
Top Sellers
| 1 | -$1.19M | |
| 2 | -$1.03M | |
| 3 | -$331K | |
| 4 |
Renaissance Technologies
New York
|
-$242K |
| 5 |
Bank of New York Mellon
New York
|
-$215K |